Ibuprofen and acetaminophen combination dosage for dental pain

Randomized Controlled Trial

. 2020 Sep;20(3):237-247.

doi: 10.1007/s40268-020-00310-7.

Affiliations

• PMID: 32506309
• PMCID: PMC7419400
• DOI: 10.1007/s40268-020-00310-7

Free PMC article

Randomized Controlled Trial

Evaluation of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in the Treatment of Postsurgical Dental Pain: A Pilot, Dose-Ranging, Randomized Study

David Kellstein et al. Drugs R D. 2020 Sep.

Free PMC article

Abstract

Introduction: Ibuprofen and acetaminophen provide analgesia via different mechanisms of action and do not exhibit drug-drug interactions; therefore, combining low doses of each may provide greater efficacy without compromising safety.

Objectives: The present study assessed the analgesic efficacy of fixed-dose combinations (FDCs) of ibuprofen/acetaminophen (IBU/APAP) compared with ibuprofen 400 mg and placebo.

Methods: This 12-h, double-blind, proof-of-concept study compared three FDCs of IBU/APAP (200 mg/500 mg, 250 mg/500 mg, and 300 mg/500 mg) with ibuprofen 400 mg and placebo in patients with moderate-to-severe pain following third molar extraction. The primary endpoint was the time-weighted sum of pain relief and pain intensity difference scores from 0 to 8 h after dosing (SPRID[4]0-8). Time to meaningful pain relief (TMPR), duration of pain relief, and adverse events (AEs) were also assessed.

Results: In total, 394 patients were randomized. All active treatments were superior to placebo for SPRID[4]0-8 (all p < 0.001) but not significantly different from ibuprofen 400 mg. Median TMPR with FDCs and ibuprofen (44.5-54.1 and 56.2 min, respectively) was faster than with placebo (> 720 min; all p < 0.001 vs. placebo). Duration of pain relief was similar with the FDCs and ibuprofen 400 mg (9.7 -11.1 h) and longer than with placebo (1.6 h; all p < 0.001). AE incidence was comparable with all treatments.

Conclusion: Each IBU/APAP FDC provided analgesic efficacy comparable to that with ibuprofen 400 mg and superior to that with placebo. Each FDC provided MPR in < 1 h, duration of pain relief > 9 h, and tolerability similar to that with ibuprofen and placebo. CLINICALTRIALS.

Gov registration: NCT01559259.

Conflict of interest statement

David Kellstein is a former employee of Pfizer Consumer Healthcare. Rina Leyva is a current employee of GSK Consumer Healthcare. On 1 August 2019, Pfizer Consumer Healthcare became part of GSK Consumer Healthcare.

Figures

Patient disposition. APAP acetaminophen, FDC fixed-dose combination, IBU ibuprofen

Five-point categorical pain relief rating scores over time. APAP acetaminophen, FDC fixed-dose combination, IBU ibuprofen. *p ≤ 0.001 vs. placebo. †p ≤ 0.01 vs. placebo. ‡p ≤ 0.05 vs. placebo. §p ≤ 0.01 vs. IBU 400 mg. IIp ≤ 0.05 vs. IBU 400 mg. ¶p ≤ 0.05 vs. FDC IBU/APAP 200 mg/500 mg

Mean time-weighted sum of pain relief and pain intensity difference scores. APAP acetaminophen, FDC fixed-dose combination, IBU ibuprofen, SE standard error, SPRID[4] time-weighted sum of pain relief and pain intensity difference scores based on the categorical pain severity rating scale and pain relief scores from 0–2, 0–6, 0–8, and 0–12 h. *p < 0.001 vs. placebo. †p < 0.05 vs. IBU 400 mg

Kaplan–Meier estimate of time to meaningful pain relief. APAP acetaminophen, IBU, ibuprofen. *p ≤ 0.001 vs. placebo. †p ≤ 0.05 vs. IBU 400 mg

Kaplan–Meier estimate of time to treatment failure. APAP acetaminophen, FDC fixed-dose combination, IBU ibuprofen. *p ≤ 0.001 vs. placebo

Similar articles

• Efficacy and Safety of Single and Multiple Doses of a Fixed-dose Combination of Ibuprofen and Acetaminophen in the Treatment of Postsurgical Dental Pain: Results From 2 Phase 3, Randomized, Parallel-group, Double-blind, Placebo-controlled Studies.

  Searle S, Muse D, Paluch E, Leyva R, DePadova E, Cruz-Rivera M, Kellstein D. Searle S, et al. Clin J Pain. 2020 Jul;36(7):495-504. doi: 10.1097/AJP.0000000000000828. Clin J Pain. 2020. PMID: 32271183 Clinical Trial.

• A single-tablet fixed-dose combination of racemic ibuprofen/paracetamol in the management of moderate to severe postoperative dental pain in adult and adolescent patients: a multicenter, two-stage, randomized, double-blind, parallel-group, placebo-controlled, factorial study.

  Mehlisch DR, Aspley S, Daniels SE, Southerden KA, Christensen KS. Mehlisch DR, et al. Clin Ther. 2010 Jun;32(6):1033-49. doi: 10.1016/j.clinthera.2010.06.002. Clin Ther. 2010. PMID: 20637958 Clinical Trial.

• Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.

  Litkowski LJ, Christensen SE, Adamson DN, Van Dyke T, Han SH, Newman KB. Litkowski LJ, et al. Clin Ther. 2005 Apr;27(4):418-29. doi: 10.1016/j.clinthera.2005.04.010. Clin Ther. 2005. PMID: 15922815 Clinical Trial.

• Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions: translating clinical research to dental practice.

  Moore PA, Hersh EV. Moore PA, et al. J Am Dent Assoc. 2013 Aug;144(8):898-908. doi: 10.14219/jada.archive.2013.0207. J Am Dent Assoc. 2013. PMID: 23904576 Review.

• Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain.

  Derry CJ, Derry S, Moore RA. Derry CJ, et al. Cochrane Database Syst Rev. 2013 Jun 24;2013(6):CD010210. doi: 10.1002/14651858.CD010210.pub2. Cochrane Database Syst Rev. 2013. PMID: 23794268 Free PMC article. Review.

References

1. 1. Moore RA, Wiffen PJ, Derry S, Maguire T, Roy YM, Tyrrell L. Non-prescription (OTC) oral analgesics for acute pain—an overview of Cochrane reviews. Cochrane Database Syst Rev. 2015;11:CD010794. - PMC - PubMed
2. 1. Becker DE. Pain management: part 1: managing acute and postoperative dental pain. Anesth Prog. 2010;57:67–78. doi: 10.2344/0003-3006-57.2.67. - DOI - PMC - PubMed
3. 1. Mehlisch DR. The efficacy of combination analgesic therapy in relieving dental pain. J Am Dent Assoc. 2002;133:861–871. doi: 10.14219/jada.archive.2002.0300. - DOI - PubMed
4. 1. Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth. 1997;78:606–617. doi: 10.1093/bja/78.5.606. - DOI - PubMed
5. 1. Starkweather APM. Enhanced recovery programs and pain management. Top Pain Manag. 2017;32:1–12. doi: 10.1097/01.TPM.0000513202.87691.49. - DOI

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Springer

• Medical

  • ClinicalTrials.gov
  • MedlinePlus Health Information